Cinqair Prices, Coupons and Patient Assistance Programs
Cinqair (reslizumab) is a member of the interleukin inhibitors drug class and is commonly used for Asthma.
The cost for Cinqair intravenous solution (10 mg/mL) is around $1,115 for a supply of 10 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Cinqair prices
Intravenous Solution
Quantity | Per unit | Price |
---|---|---|
10 milliliters | $111.52 | $1,115.15 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Cinqair Coupons, Copay Cards and Rebates
Cinqair offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Cinqair Cost Support Program
Eligible commercially insured patients may pay $0 per monthly dose of medication and its administration; maximum savings of up to $10,000 per year; for additional information contact the program at 844-838-2211.
- Applies to:
- Cinqair
- Number of uses:
- 12 fills per year
Form more information phone: 844-838-2211 or Visit website
Patient Assistance & Copay Programs for Cinqair
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Cinqair (reslizumab) Injection; IV
More information please phone: 866-316-7263 Visit Website
Provider: Teva Support Solutions: Cinqair
Eligibility requirements:- Contact program for details.
- Varies
- Medically appropriate condition/diagnosis
- The patient must also be a US resident.
- Co-payment assistance and patient assistance programs are available for eligible patients. Education and support services are available; Contact program for details.
- Cinqair (reslizumab) Injection; IV
More information please phone: 844-838-2211 Visit Website
More about Cinqair (reslizumab)
- Check interactions
- Compare alternatives
- Reviews (8)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español